Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Use of a Long Acting GnRH Antagonist (Degarelix) in Controlled Ovarian Hyperstimulation in PCOS Women at a Risk to Developing OHSS Undergoing IVF : a Pilot Study

NCT02084940 is registered in ClinicalTrials.gov with Bioroma as lead sponsor.

NCT NCT02084940
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02084940 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Use of a Long Acting GnRH Antagonist (Degarelix) in Controlled Ovarian Hyperstimulation in PCOS Women at a Risk to Developing OHSS Undergoing IVF : a Pilot Study
Lead sponsor
Bioroma
Phase
Observational
Overall status
Unknown status
Start date
March 31, 2014
Completion date
February 28, 2015
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

invitro fertilization, ovarian hyperstimulation syndrome, polycystic ovarian syndrome